OTCMKTS:CVALF Covalon Technologies (CVALF) Stock Price, News & Analysis $1.90 +0.09 (+4.97%) As of 07/3/2025 11:28 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About Covalon Technologies Stock (OTCMKTS:CVALF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Covalon Technologies alerts:Sign Up Key Stats Today's Range$1.84▼$1.9050-Day Range$1.63▼$2.0552-Week Range$1.46▼$3.08Volume3,100 shsAverage Volume3,570 shsMarket Capitalization$52.10 millionP/E Ratio21.11Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada. Read More Receive CVALF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CVALF Stock News HeadlinesCovalon Technologies Ltd. (CVALF) Q2 2025 Earnings Call TranscriptMay 28, 2025 | seekingalpha.comCovalon Reports Fifth Consecutive Quarter of Positive EarningsMay 28, 2025 | financialpost.comFCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave. | Crypto Swap Profits (Ad)Covalon Reports Fifth Consecutive Quarter of Positive EarningsMay 28, 2025 | financialpost.comFCovalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line GuardMay 27, 2025 | finance.yahoo.comCovalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing OpportunitiesMay 20, 2025 | financialpost.comFCovalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing OpportunitiesMay 20, 2025 | financialpost.comFCovalon Technologies Promotes Kim Crooks to COO and Board MemberMay 15, 2025 | tipranks.comSee More Headlines CVALF Stock Analysis - Frequently Asked Questions How have CVALF shares performed this year? Covalon Technologies' stock was trading at $2.24 on January 1st, 2025. Since then, CVALF shares have decreased by 15.2% and is now trading at $1.90. How were Covalon Technologies' earnings last quarter? Covalon Technologies Ltd. (OTCMKTS:CVALF) issued its earnings results on Wednesday, May, 28th. The company reported $0.01 earnings per share for the quarter, meeting the consensus estimate of $0.01. The business earned $5.27 million during the quarter, compared to analysts' expectations of $7.67 million. Covalon Technologies had a trailing twelve-month return on equity of 13.40% and a net margin of 10.95%. How do I buy shares of Covalon Technologies? Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/28/2025Today7/04/2025Next Earnings (Estimated)8/19/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryN/A Current SymbolOTCMKTS:CVALF CIKN/A Webwww.covalon.com Phone(905) 568-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)$0.09 Trailing P/E Ratio21.11 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.96 million Net Margins10.95% Pretax Margin10.93% Return on Equity13.40% Return on Assets11.59% Debt Debt-to-Equity RatioN/A Current Ratio8.39 Quick Ratio6.09 Sales & Book Value Annual Sales$22.91 million Price / Sales2.27 Cash Flow$0.10 per share Price / Cash Flow18.46 Book Value$0.74 per share Price / Book2.57Miscellaneous Outstanding Shares27,420,000Free FloatN/AMarket Cap$52.10 million OptionableNot Optionable Beta0.54 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (OTCMKTS:CVALF) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Covalon Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.